[Analysis of the Efficacy of Irinotecan in the Second-line Treatment of Refractory and Relapsed Small Cell Lung Cancer]
【伊立替康二线治疗难治性复发性小细胞肺癌疗效分析】
期刊:Chinese Journal of Lung Cancer
影响因子:
doi:10.3779/j.issn.1009-3419.2021.103.04
Xing, He; Zhang, Jie; Ge, Fengjuan; Yu, Xinhang; Bian, Huimin; Zhang, Fuliang; Fang, Jian